ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 119 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $36,288,000 | +77.9% | 2,800,000 | +100.0% | 0.96% | -18.0% |
Q2 2020 | $20,398,000 | +62.1% | 1,400,000 | -5.3% | 1.17% | +55.4% |
Q1 2020 | $12,584,000 | -74.1% | 1,478,753 | -49.9% | 0.75% | -69.6% |
Q4 2019 | $48,587,000 | +16.6% | 2,950,000 | 0.0% | 2.47% | +12.9% |
Q3 2019 | $41,654,000 | +3.6% | 2,950,000 | +47.5% | 2.19% | +16.8% |
Q2 2019 | $40,220,000 | -49.4% | 2,000,000 | 0.0% | 1.88% | -52.7% |
Q1 2019 | $79,500,000 | +20.4% | 2,000,000 | +5.3% | 3.96% | +26.5% |
Q4 2018 | $66,006,000 | -1.5% | 1,900,000 | +17.3% | 3.13% | +9.2% |
Q3 2018 | $66,987,000 | +12.5% | 1,620,000 | 0.0% | 2.87% | +25.1% |
Q2 2018 | $59,535,000 | -5.6% | 1,620,000 | +0.2% | 2.29% | -26.0% |
Q1 2018 | $63,051,000 | +550.5% | 1,616,690 | +201.9% | 3.10% | +553.2% |
Q4 2017 | $9,693,000 | +9.4% | 535,500 | 0.0% | 0.47% | -15.7% |
Q3 2017 | $8,863,000 | +18.2% | 535,500 | 0.0% | 0.56% | +54.0% |
Q2 2017 | $7,497,000 | +191.8% | 535,500 | +328.4% | 0.36% | +251.0% |
Q1 2017 | $2,569,000 | – | 125,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |